Abstracts tagged "Atherosclerosis and myeloperoxidase (MPO)"

Abstract Number: 1827 • 2015 ACR/ARHP Annual Meeting
Plasma Myeloperoxidase Levels Are Inversely Associated with Carotid Plaque in SLE
Maureen A. McMahon^1,2, Jennifer M. Grossman^3,4,5, Lori Sahakian^6,7, Elaine Lourenco⁸, John FitzGerald^9,10, Christina Charles-Schoeman³, Alan Gorn^3,10, Michael Weisman¹¹, Daniel J Wallace^12,13, Bevra H. Hahn^3,14 and Brian Skaggs³, ¹Div of Rheumatology, UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, CA, ²Division of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ³Medicine, UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, CA, ⁴Div of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁵Rheumatology, UCLA, Los Angeles, CA, ⁶Division of Rheumatology, Department of Medicine, UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, CA, ⁷Division of Rheumatology, Department of Medicine,, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁸UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, CA, ⁹Rheumatology, UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles, CA, ¹⁰Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ¹¹Rheumatology, Cedars-Sinai Medical Center, West Hollywood, CA, ¹²Division of Rheumatology, Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA, Los Angeles, CA, ¹³Cedars-Sinai Medical Center, West Hollywood, CA, ¹⁴Rheumatology, Professor Emeritus, Department of Medicine/Rheumatology, David Geffen School of Medicine UCLA, Los Angeles, CA
Background/Purpose: : Women with SLE have increased risk of atherosclerosis (ATH) that is not adequately explained by traditional risk factors. We previously discovered that a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].